Pigment Solution Program
PreclinicalSmall molecule
Pigment Solution Program is one of 18 small molecule programs targeting Adjuvant Therapy. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
17
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
19 competitors in Adjuvant Therapy
#DrugCompanyPhaseTrials
1Herceptin
RochePhase 3
Verzenio
Eli LillyPhase 3
Xeloda
EEngelhard Arzneimittel GmbH & Co.KG
Phase 3
Tyvyt
Innovent Biologics (Suzhou) Co. Ltd.Phase 3
Conmana
BBetta Pharmaceuticals Co., Ltd.
Phase 3
Ensacove
XXcovery Holdings, Inc.
Phase 3
Imfinzi
AstraZenecaPhase 2
Beyfortus
BeiGenePhase 2
Benmelstobart
SSun Yat-sen University
Phase 3
Tuoyi
CCoherus Oncology, Inc.
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Pigment Solution Program. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- DDr.dr.Irma Bernadette, SpKK (K)